Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Friend's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at The Nurse Practitioner.
Send a copy to your email
Your message has been successfully sent to your friend.
Some error has occurred while processing your request. Please try after some time.
Save my selection
Newland, Jamesetta Less
Nurse Practitioner. 35(7):8, July 2010.
Nurse Practitioner. 35(7):9-10, July 2010.
D'Arcy, Yvonne Less
Nurse Practitioner. 35(7):11-14, July 2010.
Graham, Margaret Clark
Graham, Margaret Clark Less
Nurse Practitioner. 35(7):15, July 2010.
Nurse Practitioner. 35(7):17, July 2010.
Simmons, Susan Less
Nurse Practitioner. 35(7):18-19, July 2010.
Nurse Practitioner. 35(7):56, July 2010.
Brennan, Christine S.
Brennan, Christine S. Less
Nurse Practitioner. 35(7):20-29, July 2010.
There have been significant advancements made in the treatment of hepatitis C virus (HCV) infection, however, not all who could benefit have received access. This article reviews current guidelines for HCV treatment and proposes strategies to overcome potential barriers to state-of-the-art therapy.
Scordo, Kristine A.
Scordo, Kristine A. Less
Nurse Practitioner. 35(7):32-37, July 2010.
Although limited information about the success of lipid-lowering therapy in HIV-infected patients is available from controlled studies, current guidelines support managing dyslipidemia in these patients similar to the general population per the National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines.
Crockett-Maillet, Ginny Less
Nurse Practitioner. 35(7):39-43, July 2010.
The identification of susceptibility for hereditary cancer in asymptomatic individuals provides vital information about potential genetic risk and affords the opportunity for early intervention through genetic counseling and testing.
Savely, Virginia Less
Nurse Practitioner. 35(7):44-50, July 2010.
Lyme disease is often missed in its early stages when treatment is most successful, and years of needless morbidity and disability ensue for thousands of patients. This article presents the diagnostic challenges inherent in the diagnosis of Lyme disease and provides information about when to suspect Lyme disease and how to test for it.
Kessenich, Cathy R.
Kessenich, Cathy R. Less
Nurse Practitioner. 35(7):51-53, July 2010.
According to a task force convened by the American Society of Bone and Mineral Research, the risk of osteonecrosis of the jaw (ONJ) associated with oral bisphosphonate therapy for osteoporosis is low and estimated at 1 in 10,000 and less than 1 in 100,000 patient-treatment years. Comparatively, the risk of ONJ in patients with cancer treated with high doses of intravenous bisphosphonates is higher and estimated at 1-10 per 100 patients treated.
Nurse Practitioner. 35(7):29-30, July 2010.
Nurse Practitioner. 35(7):37-38, July 2010.